Medtech and digital health solutions growth stage investor Endeavour Vision has closed its Endeavour Medtech Growth II fund at €290.2 million in capital commitments.
New and returning LPs range from public pension funds and multi-manager funds to family offices and high-net-worth individuals.
Building on 20+ years of experience, and similar to the original Endeavour Medtech Growth fund, round 2 will carry on supporting medtech firms that advance healthcare standards and optimise efficiency.
“Governments, citizens and investors are now more aware than ever of our healthcare systems’ strategic importance and current limitations,” comments Endeavour Vision co-founder and managing partner Bernard Vogel. “This is accelerating the demand for pioneering solutions that can deliver sustainable healthcare. As such, EMG II LP’s timing could not be better.”
Founded in 2000 by Bernard Vogel, Damien Tappy, and Sven Lingjaerde, Endeavour Vision is one of the largest funds focused specifically on medtech and digital health. To date, the fund has deployed over €414.7 million and invested in 42 companies, half of which have exited via acquisition or IPO.